AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Efficacy of Modified Olfactory Training Method for Patients With Post-viral Olfactory Dysfunction

RecruitingNAAges 18 Years - 80 YearsAllPeking University Third Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to validate the effectiveness of the modified olfactory training device, the main questions it aims to answer are: Is the modified olfactory training device effective in treating patients with post-viral olfactory dysfunction? Compared to the conventional device, how efficient is the modified olfactory training device for improving olfactory function?

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age 18-80 years old, gender not limited. 2. Patients diagnosed with olfactory dysfunction following infections of the upper respiratory tract, as determined by Sniffin' Sticks test (including TDI value test). 3. Voluntarily signs the informed consent form. Exclusion Criteria: 1. Patients with post-traumatic olfactory dysfunction, rhinosinusitis-related dysfunction and olfactory dysfunction caused by other reasons. 2. Patients with concomitant sinonasal disease. 3. Patients with chronic diseases, such as hypertension, diabetes, bronchopneumonia, chronic obstructive pulmonary disease, etc. 4. Patients with serious coexisting diseases: such as malignant tumors, etc., with a life expectancy of less than 2 years. 5. Patients who cannot tolerate olfactory function testing and treatment. 6. Patients who have taken oral glucocorticoids, antibacterial drugs, anti-leukotrienes, antihistamines, or received olfactory training within four weeks will be excluded. 7. Patients who are receiving treatment that affects olfactory recovery. 8. Patients with smoking habits. 9. Patients who are already or plan to be pregnant. 10. According to the judgment of the researchers, the patient cannot complete this study or cannot comply with the requirements of this study (such as memory or behavior abnormalities, depression, heavy drinking, previous breach of contract). 11. Patients who did not consent for participating in the study.
๐Ÿ’Š

What it tests

  • Conventional olfactory training device
  • Modified olfactory training device
  • Conventional olfactory training device with placebo
๐Ÿ“

Where

1 site
Bejing
Beijing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy